Britain's AstraZeneca said on Friday it would investigate combining its experimental COVID-19 vaccine with Russia's Sputnik V vaccine candidate, a move Russian scientists have suggested could sharply boost efficacy. The developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.